BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14710208)

  • 1. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
    Mabed M; El-Helw L; Shamaa S
    Br J Cancer; 2004 Jan; 90(1):65-9. PubMed ID: 14710208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression.
    Yang P; Jiang Y; Pan Y; Ding X; Rhea P; Ding J; Hawke DH; Felsher D; Narla G; Lu Z; Lee RT
    Sci Rep; 2019 Apr; 9(1):6428. PubMed ID: 31015523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.
    Twardziok M; Meierhofer D; Börno S; Timmermann B; Jäger S; Boral S; Eggert A; Delebinski CI; Seifert G
    BMC Complement Altern Med; 2017 Apr; 17(1):237. PubMed ID: 28454538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
    Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemical profile and therapeutic potential of Viscum album L.
    Nazaruk J; Orlikowski P
    Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts.
    Werthmann PG; Kindermann L; Kienle GS
    Complement Med Res; 2019; 26(4):276-279. PubMed ID: 30897582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series.
    Lee RT; Yang P; Alahmadi A; McQuade J; Yuan E; Difeo A; Narla G; Kaseb A
    Case Rep Oncol; 2021; 14(1):224-231. PubMed ID: 33776708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Evaluation of Antitumoral and Cytotoxic Properties of Viscum album Fraxini Extract on Pediatric Tumor Cells.
    Menke K; Schwermer M; Schramm A; Zuzak TJ
    Planta Med; 2019 Oct; 85(14-15):1150-1159. PubMed ID: 31590196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete, Durable Remission of Advanced Hepatocellular Carcinoma under Treatment with Viscum album Extracts: A Case Report.
    Orange M; Poidimani N; Crosignani A; Werthmann PG; Bertotto C
    Complement Med Res; 2022; 29(6):483-491. PubMed ID: 35764068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.
    Tröger W; Galun D; Reif M; Schumann A; Stanković N; Milićević M
    Eur J Cancer; 2013 Dec; 49(18):3788-97. PubMed ID: 23890767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.
    Kienle GS; Grugel R; Kiene H
    BMC Complement Altern Med; 2011 Aug; 11():72. PubMed ID: 21871125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
    Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
    Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
    von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma.
    Twardziok M; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
    PLoS One; 2016; 11(9):e0159749. PubMed ID: 27589063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
    Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
    Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of K562 Leukemia Cells to Doxorubicin by the Viscum album Extract.
    Srdic-Rajic T; Tisma-Miletic N; Cavic M; Kanjer K; Savikin K; Galun D; Konic-Ristic A; Zoranovic T
    Phytother Res; 2016 Mar; 30(3):485-95. PubMed ID: 26692465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
    Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
    BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.